Airway diseases
Interstitial lung diseases
Paediatric respiratory diseases
PDW12 Professional development workshop
Ethical issues in clinical respiratory research: where to draw the line?
Translational
Registration for this session is additional to the congress registration fee and is: €38.5 standard and €44 on site.
Aims : to discuss potential ethical issues associated with translating findings/knowledge from basic science to clinical trials in humans; to conduct group discussions led by expert speakers regarding if and where we should draw the (ethical) line in the advance of science to therapies; to discuss scientific advances and ethical considerations of two new technologies, CRISPR/Cas9-based genome editing and (modified) stem cell therapies.
Target audience :
Clinical researcher, General practitioner, Patient, Scientist (basic, translational), Student, Trainee
Methods :
Cell and molecular biology, General respiratory patient care
14:00
Introduction
1
4879
14:15
The potential of CRISPR/Cas9 genome editing approaches for respiratory disease
C. O'Callaghan(London, United Kingdom)
COI
D. Sipp(, Japan)
COI
2
4880
15:00
Potential gains versus ethical considerations in the use of stem cell therapies for chronic lung diseases
D. Wagner(Lund, Sweden)
COI
D. Weiss(Burlington, United States)
COI
3
4881
15:45
Closing discussion
4
4882
. . .
